stockmarketproxy
/
BLCONYSE SEC EDGAR

Bausch & Lomb Corp

Ophthalmic Goods·VAUGHAN, A6·FY end 12/31·CIK 1860742
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

4-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022Trend
Revenue$5.1B$4.8B$4.1B$3.8B
Gross Profit—————
Operating Income$113.0M$162.0M$130.0M$207.0M
Net Income-$360.0M-$317.0M-$260.0M$6.0M
Operating CF$283.0M$232.0M-$17.0M$345.0M
Capex$349.0M$291.0M$181.0M$175.0M
Free Cash Flow-$66.0M-$59.0M-$198.0M$170.0M
Buybacks—————
Dividends—————
Gross Margin—————
Operating Margin2.2%3.4%3.1%5.5%
Net Margin-7.1%-6.6%-6.3%0.2%
FCF Margin-1.3%-1.2%-4.8%4.5%
R&D / Revenue—————
Effective Tax-11.0%-30.3%-49.4%79.5%
Debt / Equity1.561.471.330.34
Buybacks / FCF—————

Peer comparison

Ophthalmic Goods · 1 peer
CEO Pay Ratio
BLCO
632:1
COO
331:1
CEO total comp
BLCO
—
COO
$16M
Net Margin
BLCO
-7.1%
COO
9.2%